[1]
A. Rzeszotarska, A. Stodolska-Nowak, J. Kufel-Grabowska, B. Nowakowski, and J. Kocięcki, “Ocular side effects of the taxane-based chemotherapy – do only vascular disorders matter?”, OncoReview, vol. 9, no. 3(35), pp. 59-63, Sep. 2019.